A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy

This study has been terminated.

Study NCT00036621 Information provided by Bristol-Myers Squibb

First Received: May 11, 2002 Last Updated: February 27, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Primary Completion Date:	September 2002 (Final data collection date for primary outcome measure)